Advaxis, Inc.
(Other OTC/NBB : ADXS)

( )
ADXS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.01%177.180.7%$1153.99m
LLYEli Lilly & Co. -0.05%371.791.1%$1049.81m
MRKMerck & Co., Inc. 0.70%110.860.7%$1003.98m
PFEPfizer Inc. 3.12%51.810.9%$984.69m
ABBVAbbVie, Inc. 0.28%165.871.9%$890.99m
BMYBristol-Myers Squibb Co. 0.00%79.931.1%$735.65m
AZNAstraZeneca Plc 0.47%69.171.0%$348.90m
HZNPHorizon Therapeutics Plc 0.63%96.915.4%$294.05m
GSKGSK Plc -0.77%36.600.3%$252.86m
IDXXIDEXX Laboratories, Inc. 2.01%428.543.9%$192.93m
NVSNovartis AG -0.15%91.590.2%$184.83m
ALNYAlnylam Pharmaceuticals, Inc. 2.89%238.018.0%$173.86m
CTLTCatalent, Inc. -3.53%45.561.9%$170.36m
NVONovo Nordisk A/S 2.08%127.840.1%$148.14m
SNYSanofi -2.13%46.920.2%$140.27m

Company Profile

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.